Skip to main content
logo
Sonnet BioTherapeutics Holdings, Inc. (SONN)
NASDAQ: SONN · Real-Time Price · USD
3.130
-0.040 (-1.26%)
At close: Sep 3, 2025, 4:00 PM
3.140
+0.010 (0.32%)
Pre-market: Sep 4, 2025, 8:41 AM EDT

Revenue by Product

Fiscal year is October - September.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Sep '24 Sep '23 Sep '22 Sep '21 Dec '19 2017 - 2019
Immuno-oncology Treatments
18.63K
Log In
Log In
Log In
Log In
Upgrade
Immuno-oncology Treatments Growth
-87.40%
Log In
Log In
Log In
Log In
Upgrade
Restaurant
-
Log In
Log In
Log In
Log In
Upgrade
Franchise
-
Log In
Log In
Log In
Log In
Upgrade
Gaming
-
Log In
Log In
Log In
Log In
Upgrade
Management Fee Income
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is October - September.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Sep '24 Sep '23 Sep '22 Sep '21 Dec '19 2017 - 2019
United States
18.63K
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-87.40%
Log In
Log In
Log In
Log In
Upgrade
United States and United Kingdom
-
Log In
Log In
Log In
Log In
Upgrade